medigraphic.com
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

2007, Number 3

<< Back Next >>

Rev Invest Clin 2007; 59 (3)

Patient and technique survival in continuous ambulatory peritoneal dialysis in a single center of the west of Mexico

Rojas-Campos E, Alcántar-Medina M, Cortés-Sanabria L, Martínez-Ramírez HR, Camarena JL, Chávez S, Flores A, Nieves JJ, Monteón F, Gómez-Navarro B, Cueto-Manzano AM

Language: English
References: 22
Page: 184-191
PDF size: 94.14 Kb.


ABSTRACT

Introduction. In Mexico, CAPD survival has been analyzed in few studies from the center of the country. However, there are concerns that such results may not represent what occurs in other province centers of our country, particularly in our geographical area. Aim. To evaluate the patient and technique survival on CAPD of a single center of the west of Mexico, and compare them with other reported series. Design. Retrospective cohort study. Setting. Tertiary care, teaching hospital located in Guadalajara, Jalisco. Patients. Patients from our CAPD program (1999-2002) were retrospectively studied. Interventions. Clinical and biochemical variables at the start of dialysis and at the end of the follow-up were recorded and considered in the analysis of risk factors. Main outcome measures. Endpoints were patient (alive, dead or lost to follow-up) and technique status at the end of the study (June 2002). Results. 49 patients were included. Mean patient survival (± SE) was 3.32 ± 0.22 years (CI 95%: 2.9-3.8 years). Patients in the present study were younger (39 ± 17yrs), had larger body surface area (1.72 ± 0.22 m2), lower hematocrit (25.4 ± 5.2%), albumin (2.6 ± 0.6g/dL), and cholesterol (173 ± 44 mg/dL), and higher urea (300 ± 93mg/dL) and creatinine (14.9 ± 5.6 mg/ dL) than those in other Mexican series. In univariate analysis, the following variables were associated (p ‹ 0.05) to mortality: pre-dialysis age and creatinine clearance, and serum albumin and cholesterol at the end of follow-up. In multivariate analysis, only pre-dialysis creatinine clearance (RR 0.66, p = 0.03) and age (RR 1.08, p = 0.005) significantly predicted mortality. Mean technique survival was 2.83 ± 0.24 years (CI 95%: 2.4- 3.3). Pre-dialysis age (p ‹ 0.05), peritonitis rate (p ‹ 0.05), and serum phosphorus at the end of follow-up (p ‹ 0.05) were associated with technique failure in univariate analysis, while in multivariate analysis, only pre-dialysis age (RR 1.07, p = 0.001) and peritonitis rate (RR 481, p ‹ 0.0001) were technique failure predictors. Conclusions. Patients from this single center of the west of Mexico were younger, had higher body surface area and initiated peritoneal dialysis with a more deteriorated general status than patients reported in other Mexican series; in spite of the latter, patient and technique survival were not different. In our setting, pre-dialysis older age and lower CrCl significantly predicted mortality, while older predialysis age and higher peritonitis rate predicted technique failure.


REFERENCES

  1. Cueto-Manzano AM. Peritoneal dialysis in Mexico. Kidney Int 2003; 63 (Suppl. 83): S90-S92.

  2. Guo A, Mujais S. Patient and technique survival on peritoneal dialysis in the United States: evaluation in large incident cohorts. Kidney Int 2003; (Suppl. 88): S3-S12.

  3. Parfrey PS, Foley RN. The clinical epidemiology of cardiac disease in chronic renal failure. J Am Soc Nephrol 1999; 10: 1606-15.

  4. Chung SH, Heimbürger O, Stenvinkel P, Qureshi RA, Lindholm B. Association between residual renal function, inflammation and patient survival in new peritoneal dialysis patients. Nephrol Dial Trasplant; 2003; 18: 590-7.

  5. Avram MM, Blaustein D, Fein PA, Goel N, Chattopadhyay J, Mittman N. Hemoglobin predicts long-term survival in dialysis patients: A 15-year single-center longitudinal study and a correlation Trend between prealbumin and hemoglobin. Kidney Int 2003; 64(Suppl. 87): S6-S11.

  6. Jager KJ, Merkus MP, Dekker FW, Boeschoten EW, Tijssen JGP, Stevens P, Bos WJW, Krediet RT. For of NECOSAD study group: Mortality and technique failure in patients starting chronic peritoneal dialysis: results of the Netherlands Cooperative Study on the adequacy of dialysis. Kidney Int 1999; 55: 1476-85.

  7. Fried L, Bernardini J, Piraino B. Charlson comorbidity Index as a predictor of outcomes in incident peritoneal dialysis patients. Am J Kidney Dis 2001; 37: 337-42.

  8. Cueto-Manzano AM, Quintana-Piña E, Correa-Rotter R. Long-term CAPD survival and analysis of mortality risk factors: 12 years experience of a single Mexican center. Perit Dial Int 2001; 21: 148-53.

  9. Paniagua R, Amato D, Vonesh E, Correa-Rotter R, Ramos A, Moran J, Mujais S, for the Mexican Nephrology Collaborative Study Group. Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol 2002; 13: 1307-20.

  10. Huisman RM, Nieuwenhuizen MGM, de Charro FTh. Patient- related and centre-related factors influencing technique survival of peritoneal dialysis in The Netherlands. Nephrol Dial Transplant 2002; 17: 1655-60.

  11. Schaubel OF, Blake PG, Fenton S. Effect of renal center characteristics on mortality and technique failure on peritoneal dialysis. Kidney Int 2001; 60: 1517-24.

  12. Su-Hernández L, Abascal-Macías A, Méndez-Bueno FJ, Paniagua R, Amato D. Epidemiologic and demographic aspects of peritoneal dialysis in Mexico. Perit Dial Int 1996; 16: 362-65.

  13. Gulati S, Stephens D, Balfe JA, Secker D, Harvey E, Balfe JW. Children with hypoalbuminemia on continuous peritoneal dialysis are at risk for technique failure Kidney Int 2001; 59: 2361-67

  14. A Lupo, Tarchini R, Carcarini G, Catizone L, Cocchi R, De Vecchi A, Viglino G, Salomone M, Segoloni G, Giangrande A. Long-term outcome in continuous ambulatory peritoneal dialysis: A 10-year-survey by the Italian Cooperative Perito- neal Dialysis Study Group. Am J Kidney Dis 1994; 24: 826-37

  15. Xue JL, Everson SE, Constantini EG, Beben JP, Chen SC, Agodoa LY, Collins AJ. Peritoneal and hemodialysis II. Mortality risk associated with initial patient characteristics. Kidney Int 2002; 61: 741-46.

  16. Chung SH, Heimbürger O, Stenvinkel P, Qureshi AR, Lindholm B. Association between residual renal function, inflammation and patient survival in new peritoneal dialysis patients. Nephrol Dial Transplant 2003; 18: 590-97.

  17. Stack AG, Molony DA, Rahman NS, Dosekun A, Murthy B. Impact of dialysis modality on survival of new ESRD patients with congestive heart failure in the United States. Kidney Int 2003; 64: 1071-79.

  18. NKF-K/DOQI, Clinical practice guidelines for peritoneal dialysis adequacy: update 2000. Am J Kidney Dis 2001; 37(Suppl. 1): S65-S136.

  19. Vonesh EF, Moran J. Mortality in end-stage renal disease: a reassessment of differences between patients treated with hemodialysis and peritoneal dialysis. J Am Soc Nephrol 1999; 10: 354-65.

  20. Schaubel DE, Fenton S. Trends in mortality on peritoneal dialysis: Canada, 1981-1997. J Am Soc Nephrol 2000; 11: 126-33.

  21. Kawaguchi Y, Hasegawa T, Nakayama M, Kubo H, Shigematu T. Issues affecting the longevity of the continuous peritoneal dialysis therapy. Kidney Int 1997; 52 Suppl: S105-S107.

  22. Collins AJ, Hao W, Xia H, Ebben JP, Everson SE, Constantini EG, Ma JZ. Mortality Risks of Peritoneal Dialysis and Hemodialysis. Am J Kidney Dis 1999; 34: 1065-74.




2020     |     www.medigraphic.com